Fact CheckerSign in

NCT06993662CompletedPhase 1

The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.

The Effectiveness and Efficacy of the Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective for Patients With Mental Health Disorders

Source: ClinicalTrials.gov · Last updated 4 Aug 2026

Brief summary (registry, in English)

The combination of pharmacotherapy and individual cognitive behavioral therapy in a private practice.

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
107 (actual)
First submitted
23 Apr 2025
Start date
2 Jun 2025
Primary completion date
3 Aug 2026
Lead sponsor
Rakitzi, Stavroula
NCT number
NCT06993662

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 107
  • From 2 Jun 2025 to the primary completion date, 3 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \*Substance abuse and head injury.

Who the study is looking for

  • age 18-65,
  • IQ ≥ 80,
  • Diagnosis: anxiety disorders, depression, obsessive-compulsive disorders, PTSD, personality disorders, bipolar disorders, schizophrenia and psychotic disorders.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE
Coordinator of this site? Confirm its status		AthensGreeceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.